Have your own idea? Try our Stock Screener
Hong Kong (HSI) Drug Retail Industry Analysis
UpdatedAug 16, 2026
DataAggregated Company Financials
Companies6
- 7D-2.0%
- 3M-17.0%
- 1Y-39.3%
- YTDn/a
Over the last 7 days, the Drug Retail industry has dropped 2.0%, driven by Alibaba Health Information Technology declining 9.4%. However, the industry is down 39% over the past year. Looking forward, earnings are forecast to grow by 15% annually.
Industry Valuation and Performance
Has the Hong Kong Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 16 Aug 2026 | HK$197.3b | HK$150.4b | HK$9.7b | 29.6x | 20.3x | 1.3x |
| Tue, 14 Jul 2026 | HK$190.5b | HK$143.0b | HK$8.7b | 30.2x | 21.9x | 1.3x |
| Thu, 11 Jun 2026 | HK$200.1b | HK$143.0b | HK$8.7b | 33.7x | 23x | 1.4x |
| Sat, 09 May 2026 | HK$248.3b | HK$140.9b | HK$8.7b | 43.8x | 28.7x | 1.8x |
| Mon, 06 Apr 2026 | HK$263.3b | HK$139.4b | HK$8.6b | 46.6x | 30.7x | 1.9x |
| Wed, 04 Mar 2026 | HK$281.5b | HK$129.3b | HK$6.9b | 38.2x | 40.6x | 2.2x |
| Fri, 30 Jan 2026 | HK$350.2b | HK$128.5b | HK$6.9b | 49.7x | 50.9x | 2.7x |
| Sun, 28 Dec 2025 | HK$308.4b | HK$126.9b | HK$6.8b | 38.8x | 45.4x | 2.4x |
| Tue, 25 Nov 2025 | HK$330.0b | HK$122.6b | HK$6.2b | 58.8x | 53.5x | 2.7x |
| Thu, 23 Oct 2025 | HK$336.8b | HK$122.1b | HK$6.1b | 61.9x | 54.9x | 2.8x |
| Sat, 20 Sep 2025 | HK$382.4b | HK$122.4b | HK$6.2b | 68.3x | 62.2x | 3.1x |
| Mon, 18 Aug 2025 | HK$325.9b | HK$122.6b | HK$5.1b | 55x | 63.9x | 2.7x |
| Wed, 16 Jul 2025 | HK$250.2b | HK$115.5b | HK$4.5b | 47x | 55.5x | 2.2x |
| Fri, 13 Jun 2025 | HK$236.4b | HK$115.4b | HK$4.5b | 48.9x | 52.5x | 2x |
| Sun, 11 May 2025 | HK$223.4b | HK$111.0b | HK$4.2b | 61.8x | 53.4x | 2x |
| Tue, 08 Apr 2025 | HK$173.7b | HK$109.7b | HK$4.1b | 49.4x | 42x | 1.6x |
| Thu, 06 Mar 2025 | HK$233.9b | HK$104.0b | HK$3.6b | 56.1x | 65x | 2.2x |
| Sat, 01 Feb 2025 | HK$178.0b | HK$104.5b | HK$3.6b | 40.6x | 49.2x | 1.7x |
| Mon, 30 Dec 2024 | HK$158.9b | HK$103.3b | HK$3.6b | 37.9x | 44.4x | 1.5x |
| Wed, 27 Nov 2024 | HK$165.3b | HK$104.5b | HK$3.6b | 37.6x | 45.7x | 1.6x |
| Fri, 25 Oct 2024 | HK$167.7b | HK$104.7b | HK$3.3b | 47.3x | 50.5x | 1.6x |
| Sun, 22 Sep 2024 | HK$147.5b | HK$105.9b | HK$3.4b | 39.8x | 43.9x | 1.4x |
| Tue, 20 Aug 2024 | HK$140.4b | HK$105.0b | HK$3.0b | 38.1x | 47.1x | 1.3x |
| Thu, 18 Jul 2024 | HK$143.1b | HK$102.0b | HK$2.4b | 44x | 59.9x | 1.4x |
| Sat, 15 Jun 2024 | HK$154.4b | HK$102.1b | HK$2.4b | 46.6x | 64.6x | 1.5x |
| Mon, 13 May 2024 | HK$165.0b | HK$103.8b | HK$2.3b | 49.2x | 70.8x | 1.6x |
| Wed, 10 Apr 2024 | HK$146.5b | HK$103.9b | HK$2.3b | 43.7x | 62.8x | 1.4x |
| Fri, 08 Mar 2024 | HK$165.7b | HK$105.0b | -HK$1,455,399,087.41 | 54.1x | -113.9x | 1.6x |
| Sun, 04 Feb 2024 | HK$148.4b | HK$105.1b | -HK$1,456,303,487.00 | 48.1x | -101.9x | 1.4x |
| Tue, 02 Jan 2024 | HK$209.8b | HK$106.6b | -HK$1,470,186,612.00 | 64.7x | -142.7x | 2x |
| Thu, 30 Nov 2023 | HK$208.8b | HK$105.8b | -HK$1,465,984,563.00 | 66.3x | -142.5x | 2x |
| Sat, 28 Oct 2023 | HK$205.0b | HK$101.7b | -HK$1,734,370,233.00 | 86x | -118.2x | 2x |
| Mon, 25 Sep 2023 | HK$231.8b | HK$102.4b | -HK$1,675,940,225.00 | 101.3x | -138.3x | 2.3x |
| Wed, 23 Aug 2023 | HK$222.7b | HK$102.4b | -HK$2,685,961,690.00 | 73.3x | -82.9x | 2.2x |
Price to Earnings Ratio
-82.9x
Current Industry PE
- Investors are pessimistic on the Hong Kong Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 22.5x which is lower than its 3-year average PE of 101x.
- The 3-year average PS ratio of 1.9x is higher than the industry's current PS ratio of 1.4x.
Past Earnings Growth
- Total earnings for the Drug Retail industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 12% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Comparison
How does Hong Kong Drug Retail compare with similar industries?
| HK Market | -1.30% | |
| Consumer Staples | 1.15% | |
| Food and Staples Retail | 0.53% | |
| Drug Retail | -2.02% | |
| Food Retail | 5.71% | |
| Food Distributors | -1.24% | |
| Big Box Super Stores | -4.86% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 6618 JD Health International | HK$39.50 | 1.4% +HK$1.8b | -35.5% | PE17.4x | |
| 2290 Lung Fung Group Holdings | HK$3.75 | 13.6% +HK$225.0m | n/a | PE7x | |
| 9886 Dingdang Health Technology Group | HK$0.77 | 5.5% +HK$50.0m | -7.2% | PS0.2x |